GE HealthCare Technologie... (GEHCV)
NASDAQ: GEHCV
· Real-Time Price · USD
56.00
-2.38 (-4.08%)
At close: Jan 04, 2023, 6:00 AM
Company Description
GE HealthCare Technologies Inc. operates as a medical technology, pharmaceutical diagnostics, and digital solutions provider.
Its products, services, and solutions enable clinicians to make informed decisions, improving patient care from diagnosis to therapy and monitoring.
The company is based in Chicago, Illinois.
GE HealthCare Technologies Inc. (NasdaqGS:GEHC.V) operates as a subsidiary of General Electric Company (NYSE:GE).
GE HealthCare Technologies Inc.
| Country | United States |
| IPO Date | Dec 15, 2022 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 51,000 |
| CEO | Peter J. Arduini |
Contact Details
Address: 500 W. Monroe Street Chicago, Illinois United States | |
| Website | https://www.gehealthcare.com |
Stock Details
| Ticker Symbol | GEHCV |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001932393 |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | 88-2515116 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| Jan Makela | Chief Executive Officer of Imaging |
| Peter J. Arduini | Pres & Chief Executive Officer |
| Helmut Zodl | Chief Financial Officer |
| George Andrew Newcomb | Controller & Chief Accounting Officer |
| Robert M. Giglietti | Vice President, Treasurer & Mang. |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 10, 2025 | ARS | Filing |
| Apr 10, 2025 | DEFA14A | Filing |
| Apr 10, 2025 | DEF 14A | Filing |
| Mar 31, 2025 | 8-K | Current Report |
| Mar 05, 2025 | 4 | Filing |
| Mar 05, 2025 | 4 | Filing |
| Mar 05, 2025 | 4 | Filing |
| Mar 05, 2025 | 4 | Filing |
| Mar 05, 2025 | 4 | Filing |
| Mar 05, 2025 | 4 | Filing |